Answer in brief
CVE-2026-105706 records a Medium severity (CVSS 5.3) vulnerability in SourceCodester Drug Recommendation System cross-site request forgery. The current sources do not mark it as known exploited. The current feed maps SourceCodester/Drug Recommendation System (generic). Check affected ranges and fixed versions before updating.
Analysis pending evidence review
HOL Guard separates source facts from reviewed analysis. See the methodology.
CVSS is 5.3. The current sources do not mark it as known exploited. Treat this as a source-backed prioritization signal, not a statement about your environment.
Analysis status
Analysis pending evidence review
Factual feed record only; HOL analysis is not approved for indexing. Read the methodology.
The current feed maps SourceCodester/Drug Recommendation System (generic). Check affected ranges and fixed versions before updating.
| Package | Affected range | Fixed version |
|---|---|---|
| SourceCodester/Drug Recommendation Systemgeneric | 1.0 | Not reported |
Published upstream
Oct 6, 2026
Evidence: source:cvelist:source_dates:source-dates:recordSource modified
Oct 6, 2026
Evidence: source:cvelist:source_dates:source-dates:recordFirst seen by HOL
Oct 6, 2026
A weakness has been identified in SourceCodester Drug Recommendation System 1.0. Affected is an unknown function. Executing a manipulation can lead to cross-site request forgery. The attack may be performed from remote. The exploit has been made available to the public and could be used for attacks.
Quoted source text, attributed separately from HOL analysis.